Literature DB >> 29103426

The Spectrum of Inflammatory Acquired Demyelinating Syndromes in Children.

Rinze Neuteboom1, Colin Wilbur2, Danielle Van Pelt3, Moses Rodriguez4, Ann Yeh2.   

Abstract

Acquired demyelinating syndromes in childhood comprise a spectrum of monophasic and recurrent inflammatory conditions of the central nervous system. Examples of monophasic conditions include, clinically isolated syndromes such as optic neuritis and transverse myelitis, as well as acute disseminated encephalomyelitis, whereas recurrent disorders include entities such as multiple sclerosis and neuromyelitis optica spectrum disorder. Knowledge about these disorders has expanded due to rigorously evaluated diagnostic criteria, magnetic resonance imaging features, outcomes, and serum biomarkers in these disorders. This review aims to provide a summary of clinical developments in pediatric acquired demyelinating syndromes, with a special focus on diagnostic criteria, neuroinflammatory markers, burden of disease in addition to current and potential future treatment options.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29103426     DOI: 10.1016/j.spen.2017.08.007

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  2 in total

1.  Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.

Authors:  C L de Mol; Y Y M Wong; E D van Pelt; I A Ketelslegers; D P Bakker; M Boon; K P J Braun; K G J van Dijk; M J Eikelenboom; M Engelen; K Geleijns; C A Haaxma; J M F Niermeijer; E H Niks; E A J Peeters; C M P C D Peeters-Scholte; B T Poll-The; R P Portier; J F de Rijk-van Andel; J P A Samijn; H M Schippers; I N Snoeck; H Stroink; R J Vermeulen; A Verrips; F Visscher; J S H Vles; M A A P Willemsen; C E Catsman-Berrevoets; R Q Hintzen; R F Neuteboom
Journal:  J Neurol       Date:  2018-03-22       Impact factor: 4.849

Review 2.  Biomarkers in Rare Demyelinating Disease of the Central Nervous System.

Authors:  Marina Boziki; Styliani-Aggeliki Sintila; Panagiotis Ioannidis; Nikolaos Grigoriadis
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.